Acme Generics

Solan, India Founded: 2005 • Age: 21 yrs Acquired By PAG
Solid and liquid formulations are manufactured as a CDMO focus.

About Acme Generics

Acme Generics is a Healthcare company based in Solan (India) founded in 2005, and was acquired by PAG in July 2021. It operates as a solid and liquid formulations are manufactured as a CDMO focus. Its focus areas include Biopharma Outsourcing, CDMO and Diversified. Its competitors include Abzena, Patheon, Syngene, Piramal Group and Panacea Biotec and 4 more; 5 of its 9 listed competitors have raised funding.

Company details

Acme Generics was established in 2005 in Solan, India, as a contract development and manufacturing organization in the pharmaceutical sector. Solid and liquid formulations for generics are produced through dedicated operations. Services encompass formulation development and production for clients, with activities centered in India. Leadership is held by Managing Director Viral Shah, overseeing strategic and CSR functions. The domain acmegenerics.in supports online presence.

  • Headquarters Solan, India
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website acmegenerics.in
  • Social LinkedIn X Facebook Instagram YouTube
  • Acquired by PAG (Jul 2021)
Key Metrics

Apps and channels of Acme Generics

its YouTube channel Acme Group has 38 subscribers and 1 videos.

Acme Group
YouTube 38 subscribers 1 videos Science & Technology
Open channel

Videos from Acme Generics

The most watched videos on Acme Generics's YouTube channel, Acme Group (38 subscribers). Click a video to play it here.

Acme Group
650 views

More on Acme Group.

Investors in Acme Generics

Acme Generics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include PAG.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Alternative investment firm
–pag.com-
Premium access

Investor details for Acme Generics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Acme Generics

The boards of the 4 registered companies of Acme Generics currently have 5 directors; the longest-serving is Ruby Shah, appointed in 2021. 27 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ruby Shah
DIN 02647731
Designated Partner01 Apr 20215 yrs 6 moAcme Generics Llp
Viral Shah
DIN 01079170
Designated Partner01 Apr 20215 yrs 6 moAcme Generics Llp, Acme Generics Private Limited, Acme Formulation Private Limited, Immacule Lifesciences Private Limited
Vikas Sharma
DIN 08810122
Whole-time director05 Aug 20215 yrs 2 moAcme Generics Private Limited, Acme Formulation Private Limited, Immacule Lifesciences Private Limited
Aswin Vikram
DIN 08895013
Director04 Oct 20215 yrsAcme Formulation Private Limited
Nikhil Kumar Srivastava
DIN 07308617
Director04 Oct 20215 yrsAcme Formulation Private Limited

People of Acme Generics

12 people are tracked at Acme Generics (4 in leadership, 8 in team).

NameRoleGroup
Managing Director & CSRLeadership
Venkat Rao S
Head Of Quality AssuranceLeadership
Pavan Kumar P
Head MSAT & Head PMT (acme Generics & Acme Formulation)Leadership
Piyush Misra
Group Head Human ResourcesLeadership
Deepak Sharma
Talent Acquisition ExecutiveTeam
Rohit Yadav
Quality Assurance SpecialistTeam
Vijay Kare
Senior Production ManagerTeam
Sunil Thakur
Sr. Executive-warehouseTeam
Amrender Thakur
Utilities And HVAC Engineering OfficerTeam
Dharmendra Singh
Deputy ManagerTeam
Aaryan Singh
Engineering StoreTeam
Amit Guleria
AnalystTeam
Premium access

Complete people profiles for Acme Generics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Acme Generics

Figures of Acme Generics Llp, the primary company behind Acme Generics, for FY 2021. Revenue was ₹264 Cr (+13% year on year). Net profit was ₹19.51 Cr (7% margin). EBITDA was ₹43.84 Cr (17% margin). Revenue has grown at a compounded annual rate of +1% over three years and +51% over five years.

  • ₹264 CrRevenue · FY 2021 · +13% YoY
  • ₹19.51 CrNet profit · 7% margin
  • ₹43.84 CrEBITDA · 17% margin
  • +1%Revenue CAGR, 3 years
  • +51%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Acme Generics Llp are on its company page.

Premium access

Detailed financial statements for Acme Generics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Acme Generics

2 dated milestones of Acme Generics across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Acme Generics is founded.
  2. Exit Acquired by PAG.

Competitors of Acme Generics

Acme Generics has 9 listed competitors in our database, 5 of them funded. They include Abzena, Patheon, Syngene, Piramal Group and Panacea Biotec, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
abzena.com2001Cambridge, United Kingdom$67.11M306
Provider of antibody discovery, cell line development, and bio analytics services
patheon.com1974Durham, United States$141M–
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
syngeneintl.com1993Bengaluru, India$85.89M5,618
Provider of contract research and manufacturing services for both small molecules and biologics
piramal.com1984Mumbai, India–204
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
panaceabiotec.com1984Ambala, India–2,095
Developer of biosimilars, vaccines and natural products
maravai.com2014San Diego, United States–650
Provides enabling tools and services in the life sciences research and bio-production industries
grandriverasepticmfg.com2010Grand Rapids, United States$16.93M293
Sterile parenteral CDMO services for development and manufacturing are offered.
insudpharma.com1977Madrid, Spain––
Finished formulations, APIs, and monoclonal antibodies are developed and manufactured.
lakepharma.com2009Belmont, United States$30M212
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
Premium access

Detailed competitors of Acme Generics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Acme Generics

The website of Acme Generics (acmegenerics.in) receives about 1.9K visits a month.

  • Monthly visits
    1.9K

    ▼ 4.8% vs previous month

Similar websites

Websites whose visitors overlap most with Acme Generics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
swissgarnier.com
100%
1.1K#13,288,880View details
galpha.com
97%
7K#5,128,365View details
pharmachemico.in
96%
2.2K#7,259,643View details
cadlay.in
96%
–#14,307,833View details
pharmavends.com
92%
–#1,043,069View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 8 similar websites and full traffic analytics for Acme Generics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 8 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

10 companies that operate in the same segment as Acme Generics (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Acme Generics

Premium access

Complete news archive for Acme Generics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Acme Generics

Acme Generics was founded in 2005.

Acme Generics is headquartered in Solan, India. It is registered at Solan, Himachal Pradesh, India.

Acme Generics was established in 2005 in Solan, India, as a contract development and manufacturing organization in the pharmaceutical sector. Solid and liquid formulations for generics are produced through dedicated operations. Services encompass formulation development and production for clients, with activities centered in India. Leadership is held by Managing Director Viral Shah, overseeing strategic and CSR functions. The domain acmegenerics.in supports online presence.

Acme Generics's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.

Acme Generics has 1 investor. Key investors include PAG.

Acme Generics is associated with 4 legal entities: Acme Generics Llp, Acme Generics Private Limited, Acme Formulation Private Limited and others.

Yes. Acme Generics was acquired by PAG in July 2021.

The legal entities of Acme Generics currently have 6 directors, including Ruby Shah, Viral Shah, Vikas Sharma and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available